March 4, 2013
Dasatinib thwarts brain cancer metastasis after bevacizumab use
Bevacizumab therapy can provide significant but temporary clinical benefit in persons with recurrent glioblastoma, acknowledged Panos Z. Anastasiadis, PhD, chair of the Department of Cancer Biology at Mayo Clinic in Jacksonville, Florida, and colleagues in their report for PLOS One. The drug causes these brain tumors to shrink by depriving them of blood nutrients, but certain proteins […]
Tags: bevacizumab therapy, blood nutrients, brain tumors, cancer cells, Department of Cancer Biology, Dr. Panos Z. Anastasiadis, Glioblastoma, Oncology Nurse Advisor, PLoS One, proteins